Postoperative Care for Gastric Neurogenic Tumors

There are two main types of gastric neurogenic lesions, and understanding the distinction is crucial for proper treatment and recovery.

The first type is malignant, known as gastric malignant peripheral nerve sheath tumor. This type of tumor differs from typical gastric cancer in terms of treatment strategy. While gastric cancer often requires lymph node dissection, the preferred treatment for gastric malignant peripheral nerve sheath tumors is localized resection of the stomach followed by targeted therapy. Unlike traditional gastric cancer treatment, systemic lymphadenectomy may not always be necessary.

The second type is gastric neurofibroma, a benign condition. This can usually be treated with endoscopic resection. However, patients should be aware that there is a risk of recurrence after removal, and therefore, regular follow-up is essential. It is highly recommended to undergo endoscopic monitoring every six months post-procedure to check for any signs of recurrence. Unlike malignant cases, there is no need for chemotherapy following treatment for benign neurofibromas.

In summary, gastric neurogenic tumors can be either benign or malignant, and each requires a tailored management approach. Malignant tumors typically require complete surgical excision followed by adjuvant targeted therapy or chemotherapy. On the other hand, benign lesions can be effectively managed with endoscopic removal and careful long-term follow-up. Patients should work closely with their healthcare providers to ensure the best possible outcomes after surgery.